Download the data sheet for more validation data and applications.


We're using the power of expression models to give translational and clinical researchers improved insights for durable immune biomarkers in

solid tumors. 

Cofactor ImmunoPrism provides comprehensive, quantitative immune profiling from only 2 sections of solid tumor FFPE tissue.

ImmunoPrism is now commercially available.

 Contact us to learn more. 

ImmunoPrism shows high concordance with flow cytometry when analyzing immune cells from PBMC samples, and accommodates degraded samples from FFPE. 

See more results when you download our data and applications sheet (above).

Save Time.                      Save Money.                Save Samples.

Cofactor ImmunoPrism delivers: 

  • Fully-analyzed and easy-to-interpret report including immune cell types and immune escape genes from only two sections of FFPE 
  • Comprehensive, quantitative characterization of solid tumor immune profiles in challenging clinical samples previously inaccessible by IHC or flow cytometry
  • Improved biological insights for immune-oncology using machine-learning based expression models

ImmunoPrism, %

Copyright © 2013-2019 Cofactor Genomics, Inc. 

Cofactor’s ImmunoPrism™ Assay is offered both for Research Use Only (not to be used as a diagnostic assay) and as a CAP-validated assay. 

 Please contact us to discuss which option is right for your application.